Maple Life Melatonin
Natural health product licensed in Canada
- Other names
- American Vitamin TM Melatonin 3mg Capsule, Dormi Vita Sleep Aid, Dr.Nutrition & Co Melatonin 3mg Capsule, NOVOVita Melatonin, North America Naturals Melatonin 3mg, Nutriland Melatonin 3mg Capsules, SMYTH Nutrition Melatonin 3mg, Selection Melatonin 3mg capsule, VitaPhane R Melatonin 3mg Capsule
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80000796
- Status
- Active licence
- Licence date
- 16 September 2005
- Revision date
- 31 January 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de silicium, cellulose, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps increase total sleep time aspect of sleep quality in people suffering from sleep restrictions or altered sleep schedule. Helps relieve daytime fatigue associated with jet lag. Helps reduce the time it takes to fall asleep in people with delayed sleep phase syndrome. Helps re-set the body's sleep-wake cycle aspect of circadian rhythm.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have a hormonal disorder, diabetes, liver or kidney disease, cerebral palsy, seizure disorders, migraine, depression and/or hypertension, or if you are taking blood pressure or sedative/hypnotic medications. If symptoms persist continuously for more than four weeks or if pain or other factors appear to be the cause of sleeplessness, consult your health care practitioner.
Source
Official Health Canada record, licence 80000796
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging